Syncona Limited — Board/Management Information 2018

Nov 1, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8886F

Syncona Limited

01 November 2018

Syncona Limited

Director Information

1 November 2018

Syncona Limited announces that Robert Hutchinson, a Non-Executive Director and Chair of the Audit Committee, has informed the Company that he has been appointed to the Board of Ravenscroft Holdings Limited, a company listed on The International Stock Exchange, with effect from 1 November 2018.

[ENDS]

Enquiries

Syncona Ltd

Annabel Clay

Tel: +44 (0) 20 7611 2031

Citco Fund Services (Guernsey) Limited

Company Secretary

Tel: +44 (0) 1481 758228

Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com  

About Syncona:

Syncona is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.

We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.

We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNLFLFXVBFBFBE